Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21331657 | 1.00 | TRPA1 (0.50) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL9325711 | 0.80 | TRPA1 (0.50) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL5855141 | 0.79 | TRPA1 (0.45) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL5855165 | 0.79 | TRPA1 (0.45) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL22206809 | 0.78 | TRPA1 (0.48) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL1462503 | 0.76 | TRPA1 (0.47) | TRPA1TAAR1ADRA2AADRA2CLMNA | |
| SCHEMBL496436 | 0.76 | TRPA1 (0.47) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL10012903 | 0.76 | TRPA1 (0.47) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 | |
| SCHEMBL1462504 | 0.76 | TRPA1 (0.47) | TRPA1TAAR1ADRA2AADRA2CLMNA | |
| SCHEMBL11330098 | 0.76 | TAAR1 (0.41) | TRPA1TAAR1ADRA2AADRA2CCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 763 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024104384-A1 | INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | NUCMITO PHARMACEUTICALS CO. LTD. (CN) | 2024-05-23 | — | — | WO | claimed |
| CN-1891220-A | Use of 2-amino-3-alkylpyrimidinone derivatives for producing medicaments | SANOFI SYNTHELABO (FR) | 2007-01-10 | — | — | CN | claimed |
| CN-1247567-C | 2-amino-3-alkylpyrimidinone derivatives as GSK3 beta inhibitors | SANOFI AVENTIS (FR) | 2006-03-29 | — | — | CN | claimed |
| US-6605656-B2 | A polyolefin alloy (containing styrene, acrylic, rubber, an ionomers as alloying polymer)blended with a polyamide and manipulated in such a manner as to selectively segregate the polyamide toward the front of melt flow of resin | VISTEON GLOBAL TECHNOLOGIES, INC. | 2003-08-12 | — | — | US | claimed |
| US-20020095006-A1 | Surface properties in thermoplastic olefin alloys | VISTEON GLOBAL TECHNOLOGIES, INC. | 2002-07-18 | — | — | US | claimed |
| EP-1211286-A1 | Improved surface properties in thermopastic olefin alloys | Visteon Global Technologies, Inc. (US) | 2002-06-05 | — | — | EP | claimed |
| WO-2024132803-A1 | FLUORESCENT PHENYL XANTHENE DYES | BASF SE (DE) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024132801-A1 | XANTHENE COMPOUNDS HAVING A WAVELENGTH IN THE RANGE FROM 650 TO 1200 NM | BASF SE (DE) | 2024-06-27 | — | — | WO | disclosed |
| CN-115175967-B | Ionic liquids for stabilizing viscosity of silicate-based coatings | 巴斯夫欧洲公司 | 2024-06-14 | — | — | CN | disclosed |
| US-11987738-B2 | C2-C3-alkenyl-substituted rylene imide dyes and curing product of curable silicon resin composition and C2-C3-alkenyl-substituted rylene imide dyes | BASF SE (DE) | 2024-05-21 | — | — | US | disclosed |
| WO-2024041944-A1 | NOVEL ANTHRAQUINONE-BASED NIR ABSORBERS | BASF SE (DE) | 2024-02-29 | — | — | WO | disclosed |
| US-11898075-B2 | Yellow light emitting device | BASF SE | 2024-02-13 | — | — | US | disclosed |
| EP-4097192-B1 | NEW RYLENE DICARBOXIMIDES | BASF SE (DE) | 2023-11-22 | — | — | EP | disclosed |
| US-4500740-A | Hydrolysis of water-insoluble organic halides | UOP INC. (US) | 1985-02-19 | — | — | US | disclosed |
| EP-0086403-A2 | 2-Oxazolidine-ones | MERCK PATENT GmbH (DE) | 1983-08-24 | — | — | EP | disclosed |
| US-4258062-A | ISOPRENALINE ANTAGONISTS EFFECTING HEART RATE AND BLOOD PRESSURE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1981-03-24 | — | — | US | disclosed |
| US-4171370-A | Phenoxy-amino-propanols | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-10-16 | — | — | US | disclosed |
| US-4136100-A | BLUE-VIOLET TO GREEN-BLUE DYEINGS ON CELLULOSE TEXTILES | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
| US-4104036-A | TO IMPROVE OCTANE RATING | ATLANTIC RICHFIELD COMPANY (US) | 1978-08-01 | — | — | US | disclosed |
| US-4006243-A | FUNGICIDE, BACTERICIDE, YEAST | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11987738-B2 | C2-C3-alkenyl-substituted rylene imide dyes and curing product of curable silicon resin composition and C2-C3-alkenyl-substituted rylene imide dyes | RTN3, C9, RER1 | TRPA1 771/4885TAAR1 426/4885ADRA2A 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.